SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is currently in the spotlight as investors debate the impact of the upcoming CLARITY Act and the company's strategy of slowing its aggressive Ethereum accumulation. The community remains deeply divided, with some traders citing potential institutional pivot points and favorable tokenization trends, while others express frustration over share price performance compared to broader market gains and the company's dilution tactics.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

SLV is experiencing a surge in investor interest driven by its critical role in AI data center infrastructure and industrial supply chain constraints. The community is actively debating the strength of this rally, with many retail investors holding firm through volatility, anticipating a push toward higher price levels despite ongoing discussions about inflation and Federal Reserve policy.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors await critical extended follow-up data for its prostate cancer drug, CAN-2409, to be presented at an upcoming plenary session. The community is actively debating the potential for a practice-changing therapy, the durability of clinical outcomes, and the possibility of a premium acquisition by Big Pharma.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is gaining traction as investors pivot toward software leaders amid aggressive institutional stake-building from major hedge funds. The community is focused on the stock's potential for a breakout as it tests key technical resistance levels, with strong debate over its valuation compared to hardware-heavy AI plays.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is facing significant volatility following a weak first-quarter earnings report, which highlighted a net loss and production delays at its Thompson Falls smelter. Despite these operational setbacks, retail investors remain divided between frustration over the missed targets and a bullish long-term thesis centered on government grants and the stock's role as a critical domestic supplier of antimony and tungsten.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing significant community discussion due to its extremely tight float, with over 90% of shares reportedly held by the CEO and near-zero availability for shorting. Traders are closely watching for a potential parabolic squeeze, drawing comparisons to previous explosive meme stock moves and citing surging borrow fees as a catalyst for a possible short-covering rally.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is facing intense bearish sentiment and significant downward pressure, with investors heavily debating whether the stock represents a deep-value turnaround opportunity or a permanent decline. The community is actively discussing rumors of potential collaborations, insider buying patterns, and the upcoming World Cup, while simultaneously venting frustrations over recent legal challenges and technical weakness.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Boost Run is capturing significant retail interest and surging on high volume following its recent de-SPAC transition and a strategic partnership announcement with CDW. Investors are actively debating the company's valuation compared to other AI infrastructure players while highlighting its NVIDIA-backed cloud status and substantial contracted revenue.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is seeing intense retail activity and a significant price rally following a 100 million dollar strategic investment from the Winklevoss Capital Fund, which investors are interpreting as a major signal of institutional conviction. While the community remains divided over the stock's long-term viability and recent performance, traders are actively discussing the potential for a short squeeze due to high short interest and anticipation surrounding upcoming regulatory developments in the crypto sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$KALV $PHVS $TAK yes love KALV and PHVS and check out ARQT as underrated but their psoriasis cream for skin projects 2 billion sales and foam for hairy areas amazing efficacy and have other skin help for another 500 million so doubling sales staff to counter shorts as they know most of retail has stop loss and use it all the time but they can see and we do not even know who shorts are. ARQT will sell if we cannot get price to 40 or 50 per share VERY

jeremyz

Citizens reiterated $KALV Market Outperform; $28 
$PHVS $TAK PHAR IONS BCRX 
Here&#39;s what Citizens said in its note: https://x.com/Quantumup1/status/2044801671402860730?s=20

Citizens reiterated $KALV Market Outperform; $28$PHVS $TAK PHAR IONS BCRXCitizens said in its note:KALV reported 4Q25 Ekterly sales of $35M handily beating consensus at the time (~ $21M), with an impressive 1,318 start forms received representing ~11% of the U.S. diagnosed... https://t.co/ookkzJ6tk7

quantumup on X (formerly Twitter): "Citizens reiterated $KALV Market Outperform; $28$PHVS $TAK PHAR IONS BCRXCitizens said in its note:KALV reported 4Q25 Ekterly sales of $35M handily beating consensus at the time (~ $21M), with an impressive 1,318 sta...

StockTwits Web

KalVista Pharmaceuticals Inc

Pharvaris NV

Takeda Pharmaceutical Co Ltd (ADR)

Quantumup

StockTwits for iOS

 yes love KALV and PHVS and check out ARQT as underrated but their psoriasis cream for skin projects 2 billion sales and foam for hairy areas amazing efficacy and have other skin help for another 500 million so doubling sales staff to counter shorts as they know most of retail has stop loss and use it all the time but they can see and we do not even know who shorts are. ARQT will sell if we cannot get price to 40 or 50 per share VERY

Kurt J Wendler

@Bornjever Watch BTBD, supernova runner potential. Look at the golden cross and the range over $2.50 and support building over $2. 
 Micro float with a drone merger with 100m in contracts

Thank You and watch UNCY and VERA as they both have PDUFA in June and July looking very good.

 Watch BTBD, supernova runner potential. Look at the golden cross and the range over $2.50 and support building over $2. 
 Micro float with a drone merger with 100m in contracts